Jazz Pharmaceuticals plc (JAZZ)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 110.75 |
| Open | 110.13 |
| Bid | 110.13 x 200 |
| Ask | 110.35 x 100 |
| Day's range | 110.01 - 112.06 |
| 52-week range | 106.61 - 146.70 |
| Volume | |
| Avg. volume | 607,850 |
| Market cap | 6.954B |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | 18.08 |
| EPS (TTM) | 6.10 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 186.06 |
PR NewswireJazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Global Health Care Conference on Wednesday, May 15, 2024, in Las Vegas. The fireside chat will be held at 10:00 a.m. PT / 1:00 p.m. ET / 6:00 p.m. IST.
- PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2024 and affirmed guidance for 2024.
ZacksArdelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Ardelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.